Joel Mases
Papers
1
Total Citations
2
H-Index
1
About
Joel Mases is a rising researcher in the field of urologic oncology, with a focused interest in the early detection and monitoring of prostate cancer. His primary research areas center on the clinical utility of liquid biopsies, specifically circulating free DNA (cfDNA), and the development of novel biomarkers to improve prognostic accuracy after radical prostatectomy. In his most cited work, "Role of Liquid Biopsy in Progressive PSA Patients after Radical Prostatectomy," Mases investigates how cfDNA levels can serve as a non-invasive tool to predict disease recurrence, addressing the critical gap where traditional clinicopathological parameters often fall short. This study, published in 2024 and already garnering 2 citations, underscores his contribution to precision oncology by exploring more dynamic and sensitive methods for tracking residual disease. Through this research, Mases is helping to pave the way for personalized surveillance strategies, offering hope for earlier intervention in patients with biochemical recurrence. His work is particularly valuable for students and clinicians seeking to understand how molecular diagnostics are reshaping post-treatment care in prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1